The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...

Humana Inc. today announced research findings that suggest inferior vena cava (IVC) filters may be overused in managed care populations, and that filters may not always be removed after they are no ...

Optional vena cava filters can used to provide either short-term or permanent protection from pulmonary embolism. These devices have recently become available for clinical use in the United States.

Unsealed court documents from lawsuits over inferior vena cava (IVC) filters expose a big gap between what manufacturers and regulators know about the safety of a medical device and how much of that ...

Venous thromboembolism is common after major trauma, and pulmonary embolism accounts for 12% of all deaths. Whether placement of a vena cava filter would benefit patients when prophylactic ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window TTHealthWatch is ...

The Crux retrievable inferior vena cava filter (VCF) represents the first significant innovation in vena cava filters in 40 years. Crux Biomedical designed the device to overcome problems associated ...